IP Library › Granted Patent US 10,667,543
Granted Patent B2
US 10,667,543 · App. 15/536,384 · Granted Jun 2, 2020

Frozen confection

Inventors: Robert Stanley Farr (Bedford, GB); Gerrit Jan Willem Goudappel (Hellevoetsluis, NL); Henk Husken (Barendrecht, NL); Daniel Anthony Jarvis (Varaignes, FR); Anke Kuijk (Eerbeek, NL); Sandra Joyce Veen (Rotterdam, NL); Krassimir Petkov Velikov (Utrecht, NL); Pieter Broer van der Weg (Berkel en Rodenrijs, NL)
Assignee: Conopco, Inc.
A23G9/42A23G9/32A23G9/38A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,667,543
App. No.
15/536,384
Granted
Jun 2, 2020
Kind
B2
Abstract

The present invention is in the field of frozen compositions. In particular, the invention relates to frozen compositions of the water ice type. The invention provides frozen confections comprising water, a freezing point depressant and defibrillated primary cell wall material comprising microfibrils. The invention also relates to a method for preparing a frozen confection comprising water, a freezing point depressant and defibrillated primary cell wall material comprising microfibrils, wherein the method includes a high shear treatment step.

Claims (37)

1. A frozen confection comprising

a. water

b. 1 to 40 wt-% of a freezing point depressant

c. 0.1 to 4 wt-% of defibrillated primary cell wall material comprising microfibrils

wherein

the primary cell wall material is sourced from plant parenchymal tissue,

at least 80 wt % of the microfibrils is smaller than 50 nm in diameter; and

wherein the frozen confection has

a microfibril availability parameter MAP of at least 0.11 Hz, or

a confection homogeneity parameter CHP of at least 0.022;

or wherein the defibrillated primary cell wall material has

a fiber defibrillation parameter FDP of at least 0.10 Hz, or

a fiber homogeneity parameter FHP of at least 0.022

and wherein the microfibril availability parameter MAP, the confection homogeneity parameter CHP, the fibre defibrillation parameter FDP, and the fiber homogeneity parameter FHP are established by the protocols as described in the description.

2. Frozen confection according to claim 1 comprising 0 to 3 wt-% of a fat that is solid at a temperature of −20° C.

3. Frozen confection according to claim 1 wherein the freezing point depressant is selected from the group consisting of monosaccharides, disaccharides, starch hydrolysates, maltodextrins, soluble fibre, polyols and mixtures thereof.

4. Frozen confection according to claim 1 also comprising ice structuring protein.

5. A method for preparing a frozen confection, wherein the frozen confection comprises

a. water;

b. 1 to 40 wt-% of a freezing point depressant; and

c. 0.1 to 4 wt-% of defibrillated primary cell wall material comprising microfibrils;

and wherein

the primary cell wall material is sourced from plant parenchymal tissue,

at least 80 wt % of the microfibrils is smaller than 50 nm in diameter;

and wherein the method comprises the steps of

i. providing a source of primary cell wall material;

ii. dispersing the primary cell wall material in an aqueous phase, thereby to form an aqueous dispersion comprising between 0.1 and 4 wt-% of the primary cell wall material;

iii. treating the aqueous dispersion to obtain a dispersion comprising defibrillated primary cell wall material, whereby the treatment includes a high shear treatment step selected from high pressure homogenisation at a pressure of between 500 and 2000 bar and microfluidising at a pressure of between 500 and 2000 bar;

iv. freezing the confection;

wherein other constituents of the frozen confection are independently mixed into the aqueous phase before step ii, between steps ii and iii, between steps iii and iv or after step iv.

6. Method according to claim 5 , wherein the aqueous dispersion of step ii comprises between 0.1 and 3 wt-%, preferably between 0.5 and 1.5 wt-% of the primary cell wall material.

7. Method according to claim 5 wherein the high shear treatment step is high pressure homogenisation at a pressure of between 500 and 1000 bar, more preferably between 600 and 800 bar.

8. Method according to claim 5 wherein the treatment in step iii is such that upon this treatment the fiber defibrillation parameter FDP of the defibrillated primary cell wall material is at least 0.10 Hz; and wherein the fiber defibrillation parameter FDP is established by the protocol as described in the description.

9. Method according to claim 5 wherein the treatment in step iii is such that upon this treatment the fiber homogeneity parameter FHP of the defibrillated primary cell wall material is at least 0.022; and wherein the fiber homogeneity parameter FHP is established by the protocol as described in the description.

10. A frozen confection obtainable by the method according to claim 5 .

11. Use of defibrillated cell wall material comprising microfibrils to reduce post-hardening of a frozen confection comprising water and 1 to 40 wt-% of a freezing point depressant, wherein the frozen confection has a microfibril availability parameter MAP of at least 0.11 Hz; and wherein the microfibril availability parameter MAP is established by the protocol as described in the description.

12. Use of defibrillated cell wall material comprising microfibrils to reduce post-hardening of a frozen confection comprising water and 1 to 40 wt-% of a freezing point depressant, wherein the frozen confection has a confection homogeneity parameter CHP of at least 0.022; and wherein the confection homogeneity parameter CHP is established by the protocol as described in the description.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2017
From: FARR, ROBERT STANLEY; GOUDAPPEL, GERRIT JAN WILLEM; HUSKEN, HENK; JARVIS, DANIEL ANTHONY; KUIJK, ANKE; VEEN, SANDRA JOYCE; VELIKOV, KRASSIMIR PETKOV; VAN DER WEG, PIETER BROER
To: CONOPCO, INC., D/B/A UNILEVER
Reel/Frame 042724/0398 →
Priority Claims (2)
EP 4199581 · Dec 22, 2014 · regional
EP 5150160 · Jan 6, 2015 · regional
Continuity (1)
Related Publication 20170360063A1 · Dec 21, 2017